IvermectinBr2nwpqd97VSaqZFy86wK2WsRmqPu6tLx6mwATQGpump

A Speculative Fever Dreams Its Final Breath

Here we observe the cadaver of IVERMECTIN, a token that arrived with the swagger of a miracle cure but departed with all the dignity of a failed clinical trial. With a mere $4,585 in liquidity and 80.5% of holdings concentrated in ten wallets, this specimen never stood a chance—a financial arrangement so top-heavy it made the tower of Pisa look structurally sound. In just forty-two days, market forces have rendered their verdict with surgical precision: -12.4% in a single day, $179 in volume, and the slow, inevitable shuffle toward zero.